CB-03-01, a new chemical entity patented by Cosmo, is a steroid ester, androgen antagonist derived from 11-deoxycortisone, which tightly mimics the profile of an ideal anti-androgen for topical use.
The objective is to create a product for topical application to treat male pattern baldness, acne and seborrhoea that does not have the side effects of products currently being taken in tablet form.
The company is completing the first phase I clinical trial for the treatment of skin disorders .
Cosmo’s patent expires in the year 2022."
That they have already taken out a patent for CB-03-01 is certainly a good sign that they intend for this thing to be sold at some point if the trials look good. Its to treat male pattern baldness, acne, hirsutism, and seborrea…all androgen-related disorders. Nice development.
Here is their product pipeline. Apparently this thing might be in phase 2 already, http://www.cosmopharmaceuticals.com/csm/activities/pipeline/